FDA

FDA approves new drug for ALS treatment

FDA approves new drug for ALS treatment

The U.S. Food & Drug Administration (FDA) has finally given its approval for a new drug for the treatment of amyotrophic lateral sclerosis (ALS).

The federal agency announced that Radicava, which is also known as edaravone, has been approved for the treatment of ALS in the United States. The only other drug tthat is available iin the nation specifically for the treatment of condition is riluzole.

Tags: 

FDA approves Radicava for Amyotrophic lateral sclerosis (ALS)

FDA approves Radicava for Amyotrophic lateral sclerosis (ALS)

The U.S. Food and Drug Administration has approved a drug for treatment of rare paralyzing disease Amyotrophic lateral sclerosis (ALS). ALS impacts nearly 12,000 to 15,000 Americans as per CDC data. The drug Radicava has been developed in Japan. The drug has been approved in Japan for treatment of stroke. Radicava or edaravone is the first drug to be approved for ALS treatment since Rilutek was approved by FDA in 1995.

Tags: 

Brineura Wins FDA Approval for Type of Batten Disease

Brineura Wins FDA Approval for Type of Batten Disease

The U.S. FDA has approved Brineura for treatment of a rare type of Batten Disease. One type of neuronal ceroid lipofuscinoses (collectively termed as Batten Disease), primarily affects the nervous system at an early age. The symptoms include language delays, ataxia and epilepsy. The symptoms usually show up between age 2 and 4 years and in certain cases, the disease even leads to vision loss.

Tags: 

FDA issues warning after finding inconsistent levels of belladonna in teething products

FDA issues warning after finding inconsistent levels of belladonna in teething products

After finding inconsistent amounts of a toxic substance called belladonna in certain homeopathic teething tablets, the U.S. Food & Drug Administration (FDA) recommend parents and caregivers not give these tablets to babies.

Homeopathic teething tablets containing belladonna are widely given to babies when they are growing their first teeth as these tablets provide temporary relief. These products have been around in the nation since the early 1900s.

Tags: 

Sabra recalls Hummus products due to Listeria risk

Sabra recalls Hummus products due to Listeria risk

The U.S. Food & Drug Administration has confirmed that Sabra Dipping Co. has issued a voluntary recall for some of its hummus products after food inspectors detected potential listeria contamination risk.

Listeria infection causes serious and sometimes fatal infections, particularly in kids, old people, and others with undermined immune systems. The long list of symptoms includes muscle aches, stiffness, fever, diarrhea and abdominal pain.

FDA looking to reclassify Nutella from topping to dessert

FDA looking to reclassify Nutella from topping to dessert

Ferrero SpA, the world’s third biggest chocolate and confectionery producer, has requested the Food & Drug Administration (FDA) to reclassify Nutella from topping to dessert, which would put the product in the same category as jam and honey.

The Italian company sought to reclassify Nutella from topping to dessert after noticing the change in the way Nutella is consumed in the U.S.

Tags: 

FDA looking to reduce Nutella’s serving size from 2 to 1 tablespoon

FDA looking to reduce Nutella’s serving size from 2 to 1 tablespoon

The Food & Drug Administration (FDA) has confirmed that it is looking to reduce Nutella’s serving size from current two tablespoons to one because the chocolate-hazelnut spread is now being used by consumers on bread, instead of as part of their desserts.

Nutella and several other nut-based cocoa spreads have to list higher serving sizes on the packaging because the government consider then as “dessert toppings.”

Tags: 

NBTY agrees to conduct advanced genetic testing to ensure its herbals products are genuine

NBTY agrees to conduct advanced genetic testing to ensure its herbals products are genuine

New York State attorney General’s office announced Wednesday that NBTY under an agreement would carry out advanced genetic testing to confirm that its herbal products comprise the ingredients being mentioned on the label.

The agreement with NBTY, one of the nation’s largest makers of popular supplements including ginkgo biloba and ginseng, is the third such kind of agreement negotiated by the office of the state attorney general, Eric T. Schneiderman.

Tags: 

FDA seeks public input on meaning of ‘healthy’ to help them quickly make healthy food choices

FDA seeks public input on meaning of ‘healthy’ to help them quickly make healthy food choices

The US Food and Drug Administration is involving public in the process of redefining nutritional claims on food labeling. The federal agency has asked Americans to share what they think ‘healthy’ means on food labels.

As per the FDA, the plan focuses both of consumers as well as the food industry. On the part of consumers, it will be easier for them to make healthy food choices. In the case of food industry, they will be able to present healthier food products.

Tags: 

3D digital breast tomosynthesis: Promising technology to detect breast cancer

3D digital breast tomosynthesis: Promising technology to detect breast cancer

A new study has suggested that a 3D mammogram can result into significant difference in detection of breast cancer tumors among women, especially the ones having dense breasts. In 2011, the US Food and Drug Administration gave green signal to 3D digital breast tomosynthesis or 3D mammography.

Pages

Subscribe to RSS - FDA